Tagged with Pharma Faces

USA Jorge Alderete, president of ALK Americas, recently spoke to PharmaBoardroom about his 20+ years with the Danish mid-cap, the challenges in communicating the USA’s challenging market access environment to a European HQ, and why new models of patient-doctor interaction and medical distribution are crucial to ALK’s future success.   A…

Pharma Faces Mouloud Boukhachab, Pierre Fabre’s managing director for Africa, the Middle East and Turkey, took on the new responsibilities of his current position in March 2020 at the beginning of the coronavirus pandemic. In a recent interview with PharmaBoardroom, Boukhachab outlined the career trajectory that has led him to his current…

USA Carol Lynch, president of Sandoz US and head of Sandoz North America, recently spoke exclusively to PharmaBoardroom about how her diverse global experiences in innovative biopharma and biosimilars are informing her leadership strategy in the US generics space. Lynch also outlines how greater uptake of biosimilar medicines can be fostered…

Romania Appointed in August 2019 to head up Bayer Romania and Moldova’s Pharmaceuticals division, 15-year Bayer veteran Jorge Levinson may be new to the market but certainly not new to the general manager position.     Every country has its challenges and opportunities Jorge Levinson, Bayer   He laughs, “this is…

Czech Republic In 1996 Jiří Žák, chairman & current CEO of FARMAK, borrowed half a billion Czech crowns to take over a state-owned producer of vitamins for which he had started working almost 30 years previously.   My goal is to continue reinvesting our profits to keep growing and leave behind a…

UAE With a combined experience of over five decades in the pharmaceutical industry including senior executive roles at companies such as Merck and Janssen, Karim Smaira and Kamel Ghammachi have come a long way with Genpharm, the Dubai-based market access company they founded in 2012. After years of learning the ins…

Hungary As general manager of the Hungarian affiliate of Swiss firm IBSA, Anna Wienner has proven herself to be a motivated pharma leader with particular expertise in reshaping and building organizations. Joining the company in 2015, Wienner took on her new position with the task of restructuring the stagnating affiliate. This…

Belgium Jean-Christophe Tellier became UCB’s CEO on January 1, 2015 only a few years joining the company in 2011. Before taking on the role Tellier held positions as executive VP of European Operations and later successfully led UCB’s BioBrands and Solutions division as executive VP as well.   Tellier was trained…

China The pharma industry tends to see a lot of personnel movement, particularly at management levels, but since the Chinese market started heating up a few years ago, the labour market has been left playing catch-up. As the Chinese government looks to streamline its regulatory approval processes, MNCs plan to expand…

Puerto Rico Over the last 22 years, Jorge Rodríguez has grown Puerto Rican industrial automation solutions provider PACIV from a one-man show to an international operator with over 100 employees.   Jorge Rodríguez’s parents were humble immigrants hailing from small villages nestled in the mountains of the Asturias region in Spain. In…

Sweden With over 110 years of existence, Getinge is a true Swedish success story. Born as a manufacturer of agricultural equipment in the small rural town on Sweden’s southwest coast from which it takes its name, the company has grown to become a world leader in medical technology. After several years…

Pharma Faces Paolo Carli, head of Middle East, Africa, Turkey, Russia and CIS (MEAR) for Merck has continually taken on greater responsibilities in the Middle East, Africa, Turkey and Eastern Europe. In his most recent interview with PharmaBoardroom, Carli talks strategy, adaptability, and sales growth.    We look at structuring markets with…